idiopathicthrombocytopenicpurpuratreatment

AlthoughthereisnoknowncauseofITPandthereisnocure,theprognosisforachildwithITPisverygood.Usually,thebodystopsmakingtheantibodies ...,,2023年6月8日—Steroids.Healthcareprovidersoftenuseanoralcorticosteroid,suchasprednisone.Whentheplateletcountisbacktoasafelevel,the ...,2023年6月8日—Onceknownasidiopathicthrombocytopenicpurpura,ITPcancausepurplebruises.Italsocancausetinyreddish-purpledotsontheskint...

Idiopathic Thrombocytopenic Purpura (ITP)

Although there is no known cause of ITP and there is no cure, the prognosis for a child with ITP is very good. Usually, the body stops making the antibodies ...

Immune thrombocytopenia (ITP)

2023年6月8日 — Steroids. Health care providers often use an oral corticosteroid, such as prednisone. When the platelet count is back to a safe level, the ...

Immune thrombocytopenia (ITP)

2023年6月8日 — Once known as idiopathic thrombocytopenic purpura, ITP can cause purple bruises. It also can cause tiny reddish-purple dots on the skin that ...

Immune Thrombocytopenia (ITP) Treatment & Management

2023年7月20日 — The guidelines suggest either prednisone (0.5-2.0 mg/kg per day) or dexamethasone (40 mg per day for 4 days) as the type of corticosteroid for ...

Immune Thrombocytopenia (ITP)

2023年8月24日 — What's the treatment for immune thrombocytopenia? ; Corticosteroids to temporarily block the antibodies that destroy platelets.

Immune thrombocytopenic purpura (ITP)

Idiopathic thrombocytopenic purpura (ITP) is a rare autoimmune disorder in ... Treatment for ITP. Treatment for ITP includes time and close observation. If ...

ITP-Immune Thrombocytopenic Purpura

由 AAJ Vaillant 著作 · 2022 · 被引用 29 次 — Therefore, splenectomy is the treatment of choice for adult patients with ITP who have persistent symptomatic thrombocytopenia. It is recommended that patients ...

Management of Immune Thrombocytopenic Purpura

由 R Warrier 著作 · 2012 · 被引用 45 次 — Treatment of ITP can be divided into medical and surgical management. Medical management is further divided into first-line and second-line pharmacotherapy.